Overview of Science Friday episode: Is a shorter course of antibiotics OK? + Genetic risk of fibromyalgia
This Science Friday episode covers two major medical topics: first, why the long-standing advice to “finish the full course” of antibiotics is being revised in light of newer research; and second, a large genetic study that identified variants linked to fibromyalgia, offering new clues about the condition’s biology and future treatment possibilities.
Shorter antibiotic courses: what’s changed?
Dr. Amy Mathers explains that the old rule to always finish every antibiotic prescription came from an earlier era of medicine, when relapse was often blamed on resistance. Newer research suggests that longer antibiotic exposure can actually increase the chances of selecting for resistant bacteria by wiping out beneficial microbiome flora and leaving harder-to-kill organisms behind.
Main points
- Longer antibiotic use can increase resistance risk
- The longer someone takes an antibiotic, the more selective pressure is placed on their microbiome.
- This can eliminate healthy bacteria and leave behind resistant strains.
- Shorter courses are often enough
- Studies now support shorter treatment durations for many infections.
- Example cited: 7 days vs. 14 days for some bloodstream infections, with 7 days often being adequate.
- Shorter treatment may reduce side effects and complications
- Less antibiotic exposure can lower the risk of C. diff infection.
- Broad-spectrum antibiotics and longer durations tend to cause more collateral damage.
- Guidelines are changing
- Infectious Diseases Society of America guidelines have been updated for some infections, including urinary tract infections.
- In many hospitals, pneumonia treatment has shifted from 14 days to 5–7 days in many cases.
Practical advice
- Don’t assume you always need an antibiotic.
- If prescribed one, ask your doctor whether the duration is evidence-based for your specific infection.
- A key question to ask: “Is 14 days really necessary, or is a shorter course typical for this condition?”
Genetic study offers new clues about fibromyalgia
The second half of the episode discusses a large-scale study led by Dr. Nasa Sinnott-Armstrong that found 26 genetic variants associated with fibromyalgia. The findings don’t provide a diagnostic test, but they help clarify that fibromyalgia has a real biological basis and appears to involve the nervous system.
Main findings
- 26 variants were identified that increase or decrease fibromyalgia risk.
- Together, they account for only about 10% of risk, so genetics is only part of the picture.
- The strongest signal points toward the nervous system, suggesting fibromyalgia may involve how the body processes pain.
- The variants were not sex-specific, meaning the genetic risk identified applies similarly across sexes.
- The study does not rule out immune system involvement or environmental triggers.
What this means
- Fibromyalgia still likely involves a mix of:
- genetics,
- environmental factors,
- triggers such as injury, infection, or severe stress.
- The research helps validate fibromyalgia as a biological condition, not “just in someone’s head.”
- It may eventually help identify subtypes of fibromyalgia and more targeted treatments.
Treatment and future research implications
- The study points to a gene called GPR52, which is also relevant in Huntington’s disease research.
- That connection could eventually guide drug development or repurposing, though it is still early.
- Researchers want to learn:
- whether GPR52-targeting drugs could help fibromyalgia,
- how nociplastic pain contributes to symptoms,
- whether different fibromyalgia subgroups have different risk factors.
Key takeaways
- Antibiotics: More is not always better; for many infections, shorter courses may be just as effective and safer.
- Fibromyalgia: New genetic evidence supports a real neurological basis for the disorder, but genetics explains only part of the risk.
- Patient advice: For both topics, the best next step is to talk with your doctor about what is truly necessary and for how long.